IDEXX LABS INC shareholders Q3 2023

IDEXX LABS INC's ticker is IDXX and the CUSIP is 45168D104. A total of 1,040 filers reported holding IDEXX LABS INC in Q3 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.

IDEXX LABS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 1,347$589,0030.36%
Paragon Advisors, LLC 1,953$8540.35%
Ninety One SA (PTY) Ltd 4,116$1,799,8040.35%
OCCUDO QUANTITATIVE STRATEGIES LP 6,164$2,695,3320.35%
Advanced Portfolio Management, LLC 943$412,3460.35%
Pine Haven Investment Counsel, Inc 762$333,2000.35%
TKG Advisors, LLC 1,166$509,8570.34%
CHILTON INVESTMENT CO INC. 24,291$10,621,7260.34%
Aberdeen Wealth Management LLC 1,018$445,1410.34%
Baird Financial Group, Inc. 279,623$122,270,7500.33%
Robeco Institutional Asset Management B.V. 276,902$121,080,9390.32%
Valley Brook Capital Group, Inc. 750$327,9530.32%
KELLEHER FINANCIAL ADVISORS 1,482$648,0330.32%
VIRGINIA RETIREMENT SYSTEMS ET AL 74,608$32,623,8400.32%
Andra AP-fonden 12,400$5,422,1480.32%
AIGEN INVESTMENT MANAGEMENT, LP 3,811$1,666,4360.31%
STF Management LP 1,351$590,7520.31%
JUPITER ASSET MANAGEMENT LTD 63,994$27,982,6570.31%
CAPE COD FIVE CENTS SAVINGS BANK 13,096$5,726,4870.31%
Bridgewater Associates 116,831$51,086,6910.31%
About IDEXX LABS INC

IDEXX Laboratories, Inc. is a leading provider of diagnostic and information technology solutions for animal health. The company offers a wide range of products and services to veterinarians, livestock producers, and pet owners worldwide. IDEXX's mission is to enhance the health and well-being of pets, people, and livestock.

IDEXX's core business is in veterinary diagnostics, which includes blood and urine tests, digital imaging, and other diagnostic services. The company's products are used to diagnose and manage a variety of animal diseases, including cancer, heart disease, and infectious diseases.

IDEXX has a strong reputation for innovation and has been recognized for its contributions to the animal health industry. The company has received numerous awards for its products and services, including the Frost & Sullivan Company of the Year Award for Animal Health Diagnostics.

IDEXX has a strong financial position, with a market capitalization of over $30 billion. The company has consistently delivered strong financial results, with revenue growth of over 10% in the most recent quarter.

In conclusion, IDEXX Laboratories, Inc. is a leading provider of diagnostic and information technology solutions for animal health. The company has a strong reputation for innovation and has been recognized for its contributions to the animal health industry. With a strong financial position and consistent revenue growth, IDEXX is well-positioned for continued success in the future.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists IDEXX LABS INC's shareholders in Q3 2023. To view IDEXX LABS INC's shareholder history, click here.